Biotechnology News

November 6, 2012

AUCKLAND, New Zealand--(BUSINESS WIRE)--Biomatters today adds Molecular Profiler application to Illumina’s BaseSpace Apps. The Molecular Profiler is a beautifully rendered, remotely managed and securely delivered cloud-based genome browser

November 6, 2012

LOS ANGELES--(BUSINESS WIRE)--Researchers present findings today at AHA Scientific Sessions: HDL3 subclasses measured with the VAP Lipid Panel are inversely associated with heart disease risk in African Americans.

November 5, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tcelna™, a novel T-cell therapy for multiple sclerosis (MS), announced today that it has signed a purchase agreement on November 5, 2012 for the...

November 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB: ILIU) announces it will host a conference call and Webcast on Wednesday, November 14, 2012 at 4:30 p.m. ET to discuss the Company’s third quarter results.

November 5, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics (CLDX) announces that results from CDX-301 Phase 1 study will be presented in a poster session at ASH 2012 Annual Meeting on 12/10/2012 at 6:00 pm ET.

November 5, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) announced today that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at three investor conferences later this month. Lazard...

November 5, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that three abstracts on its humanized anti-CD37 mono-specific protein therapeutic, TRU-016, and bispecific protein therapeutics have been accepted for...

November 5, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced preliminary financial results for the three months ended September 30, 2012 and provided a business update. In a separate announcement made today...

November 5, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced plans to restate financial statements for 2011 and the first two quarters of 2012. Ligand’s Audit Committee, in consultation with management has...

November 5, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ:CLVS) today reported financial results for the third quarter 2012, and provided an update on the progress of its clinical development programs and expected milestones for the rest of...

November 5, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

November 5, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. Reports Third Quarter 2012 Financial Results

November 5, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the third quarter of 2012. Total revenue for the quarter was $79.6 million, including approximately $17.6 million in revenue from...

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter 2012, and company highlights. “The highlights of this...

November 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the following...

November 5, 2012

NEWARK, Del.--(BUSINESS WIRE)--SDIX (Nasdaq: SDIX) - a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology and diagnostic applications - expects to release its third quarter 2012 results...

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) today announced that more than 60 abstracts from studies involving five molecules in the Company’s...

November 5, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that more than a dozen abstracts, in addition to several collaborator abstracts, for both ADCETRIS (brentuximab vedotin) and investigational antibody-drug...

November 5, 2012

BOSTON--(BUSINESS WIRE)--Goodwin Procter LLP has been named as the 2013 U.S. News-Best Lawyers’ “Law Firm of the Year” in Biotechnology Law.

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metamark Genetics Completes $13 Million Series B Financing; Announces Leadership Changes

November 5, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only New findings presented at the 2012 American Heart Association Scientific Sessions in Los Angeles provide early indications that a highly specific and selective...

November 5, 2012

GLASGOW, Scotland--(BUSINESS WIRE)--A new Open Innovation forum for researchers to access Virttu's modified oncolytic virus for new combination therapy trials

November 5, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Data presented at the American Heart Association meeting confirmed that the St. Jude Medical EnligHTN renal denervation system had a safe, effective and sustained blood pressure reduction at 6 months.

November 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--UpToDate hosted a series of forums with physicians in Mexico last week to discuss the power of clinical decision support (CDS) systems in improving patient care.

November 5, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only Following independent regulatory appraisals of the safety and efficacy of the anticoagulation therapy Pradaxa®, both the U.S. Food and Drug Administration (FDA...

November 5, 2012

SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., today announced preliminary clinical findings from an ongoing open-label Phase 2 study demonstrating the safety and efficacy of FG-4592, investigational oral hypoxia-inducible factor (HIF) prolyl...

November 5, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the prostate cancer drug market will more than double, increasing from $4.1...

November 5, 2012

SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., today announced that data from an ongoing Phase 2 study of FG-4592, an orally delivered, small molecule treatment for anemia, were presented on 2 November 2012, at the American Society of Nephrology...

November 5, 2012

TORONTO--(BUSINESS WIRE)--New healthcare scrub rental machine eliminates scrub shortages while improving infection control efforts.

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that data from its ongoing Phase 1 trial of IPI-145, the company’s potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma...

November 5, 2012

HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the U.S. Patent Office issued Patent # 8,298,560 “Methods and...

November 5, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced management changes to its executive leadership team. Mr. Allan Oberman, Senior Vice President of North America Generic Pharmaceuticals of Teva, has been...

November 5, 2012

TOKYO--(BUSINESS WIRE)--On Wednesday October 24, 2012, the Ornithine Laboratory has made a new video available to the public on its website for the 'Japan Otsukare University, Faculty of Ornithine' (literally University of Fatigue, Faculty of...

November 5, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--ReCor Medical reports 100% responder rate at one-year follow-up in clinical trial of ultrasound-based PARADISE™renal denervation system for treating resistant hypertension

November 5, 2012

SHREVEPORT, La.--(BUSINESS WIRE)--A new interview with Dr. Lane Rosen explores why the Willis-Knighton Cancer Center in Shreveport, La., sought to add proton therapy to its cancer care options.

November 5, 2012

LAFAYETTE HILL, Pa.--(BUSINESS WIRE)--IPS-Integrated Project Services, a leading, full-service engineering, construction, commissioning and qualification firm dedicated to helping clients succeed with capital projects and improve operations,...

November 5, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”, OTCBB: ACTC or the “Company”), a leader in the field of regenerative medicine announced today that it will release its third quarter 2012 financial results on Thursday,...

November 5, 2012

DURHAM, North Carolina--(BUSINESS WIRE)--Doe & Ingalls, a part of Thermo Fisher Scientific and premium provider of specialty production chemicals and customized supply-chain services to the life sciences and microelectronics industries,...

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company today announced it has been named the best large company to work for in metropolitan Boston by the Boston Globe. This year, Millennium ranked first among large companies,...

November 5, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Lee R. McCracken has been appointed Chief Executive Officer of Pathwork Diagnostics, Inc., the innovator of the Pathwork® Tissue of Origin Test.

November 5, 2012

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy for the early identification and treatment of cancer, today announced the U.S. Centers for Medicare & Medicaid Services (...

November 5, 2012

SAN DIEGO & SAN FRANCISCO--(BUSINESS WIRE)--BioNano Genomics announces its breakthrough Irys genome mapping system, empowering genomics researchers with a new way of achieving more accurate and comprehensive discoveries.

November 5, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc. today announced the presentation of key findings related to lipoprotein particles (LDL-P) and cardiovascular disease at the Annual Meeting of the American Heart Association (AHA).

November 5, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) has ranked first among U.S. healthcare companies in Newsweek magazine’s Green Rankings for the fourth time since the list’s inception in 2009. Baxter has also been named the...

November 5, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--athenahealth, Inc. (NASDAQ: ATHN), a leading provider of cloud-based practice management, electronic health record (EHR), and care coordination services to medical groups and health systems, today announced...

November 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Selventa to present at BIO-Europe 2012, and participate in panel on companion diagnostics.

November 5, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist has been named one of the Top Places to Work in Massachusetts in an annual employee-based survey from The Boston Globe. Cubist has been named to the list for five consecutive years.

November 5, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) today announced that it has received a Notice of Allowance of a U.S. patent for the use of Thymosin beta 4 (Tβ4), certain...